113 related articles for article (PubMed ID: 16585098)
21. S-Carboxymethylcysteine (S-CMC) in bronchography technique.
Nigam BK
Indian J Chest Dis Allied Sci; 1981; 23(2):81-4. PubMed ID: 7298079
[No Abstract] [Full Text] [Related]
22. ABC of chronic obstructive pulmonary disease. Pharmacological management--oral treatment.
Currie GP; Lee DK; Lipworth BJ
BMJ; 2006 Jun; 332(7556):1497-9. PubMed ID: 16793814
[No Abstract] [Full Text] [Related]
23. [Inhalation and peroral mucolytic therapy in mucoviscidosis in children].
Uglitskikh AK; Khan MA; Sharapov SV; Kapranov NI; Plisko LF
Vopr Kurortol Fizioter Lech Fiz Kult; 1996; (5):15-8. PubMed ID: 9036657
[TBL] [Abstract][Full Text] [Related]
24. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study.
Zheng JP; Kang J; Huang SG; Chen P; Yao WZ; Yang L; Bai CX; Wang CZ; Wang C; Chen BY; Shi Y; Liu CT; Chen P; Li Q; Wang ZS; Huang YJ; Luo ZY; Chen FP; Yuan JZ; Yuan BT; Qian HP; Zhi RC; Zhong NS
Lancet; 2008 Jun; 371(9629):2013-8. PubMed ID: 18555912
[TBL] [Abstract][Full Text] [Related]
25. [Mucolytic drugs: towards a contraindication in infants].
Mourdi N; Dubus JC; Bavoux F; Boyer-Gervoise M; Jean-Pastor MJ; Chalumeau M
Arch Pediatr; 2010 Jun; 17(6):735-6. PubMed ID: 20654866
[No Abstract] [Full Text] [Related]
26. Maculopapular rash to S-carboxymethylcysteine-lysine (carbocisteine).
Gomez Torrijos E; Gratacós Gómez AR; Extremera Ortega AM; Gonzalez Jimenez OM; Romo JBJ; Cañas AP; Rodriguez RG
Contact Dermatitis; 2020 Oct; 83(4):313-314. PubMed ID: 32356398
[No Abstract] [Full Text] [Related]
27. N-acetylcysteine is unlikely to reduce hospitalisation for chronic obstructive pulmonary disease.
Ernst P; Suissa S
Eur Respir J; 2003 Nov; 22(5):865; author reply 865-6. PubMed ID: 14621098
[No Abstract] [Full Text] [Related]
28. Chronic obstructive pulmonary disease.
Kerstjens H; Postma D
Clin Evid; 2002 Jun; (7):1344-57. PubMed ID: 12243121
[No Abstract] [Full Text] [Related]
29. [Using biocomplexes in therapeutic-and-prophylactic and palliative measures in chronic obstructive lung disease].
Lushchaev AIu; Vishniakov AA; Kozlov BI; Frolov NA
Adv Gerontol; 2009; 22(3):512-5. PubMed ID: 20210207
[TBL] [Abstract][Full Text] [Related]
30. [Is systemic administration of N-acetylcysteine effective?].
Gillissen A
Dtsch Med Wochenschr; 2003 Mar; 128(12):632. PubMed ID: 12649804
[No Abstract] [Full Text] [Related]
31. Fast-track pulmonary conditioning before urgent cardiac surgery in patients with insufficiently treated chronic obstructive pulmonary disease.
Dreger H; Schaumann B; Gromann T; Hetzer R; Melzer C
J Cardiovasc Surg (Torino); 2011 Aug; 52(4):587-91. PubMed ID: 21499224
[TBL] [Abstract][Full Text] [Related]
32. S-carboxymethyl-L-cysteine.
Mitchell SC; Steventon GB
Drug Metab Rev; 2012 May; 44(2):129-47. PubMed ID: 22497630
[TBL] [Abstract][Full Text] [Related]
33. [Effect of mucolytic therapy on the production of reactive oxygen species in the blood of patients with an exacerbation of chronic obstructive pulmonary disease].
Farkhutdinov UR; Farkhutdinov RR; Petriakov VV; Farkhutdinov ShU; Mirkhaĭdarov AM
Ter Arkh; 2010; 82(3):29-32. PubMed ID: 20564918
[TBL] [Abstract][Full Text] [Related]
34. [Chronic obstructive pulmonary disease exacerbation. Do we use all possibilities of outpatient therapy?].
Leshchenko IV
Ter Arkh; 2013; 85(10):83-7. PubMed ID: 24437224
[TBL] [Abstract][Full Text] [Related]
35. [ Erdosteine (Mucodox), oral administration].
J Pharm Belg; 2011 Jun; (2):55-6. PubMed ID: 21823444
[No Abstract] [Full Text] [Related]
36. Evaluation of proposed sulphoxidation pathways of carbocysteine in man by HPLC quantification.
Brockmöller J; Staffeldt B; Roots I
Eur J Clin Pharmacol; 1991; 40(4):387-92. PubMed ID: 2050173
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a stability indicating method for S-carboxymethyl-L-cysteine and related degradation products in oral syrup formulation.
Fanigliulo A; De Filippis P; Curcuruto O; Repeto P; Roveda D; Hartenstein M; Adams E; Cabooter D
J Pharm Biomed Anal; 2015 Nov; 115():39-47. PubMed ID: 26159351
[TBL] [Abstract][Full Text] [Related]
38. Polymorphic sulphoxidation of S-carboxymethyl-L-cysteine in man.
Waring RH; Mitchell SC; Shah RR; Idle JR; Smith RL
Biochem Pharmacol; 1982 Oct; 31(19):3151-4. PubMed ID: 7150344
[No Abstract] [Full Text] [Related]
39. Cytosolic sulphoxidation of S-carboxymethyl-L-cysteine in mammals.
Waring RH; Mitchell SC; O'Gorman J; Fraser M
Biochem Pharmacol; 1986 Sep; 35(18):2999-302. PubMed ID: 3753512
[No Abstract] [Full Text] [Related]
40. [Medical treatment of seromucous otitis].
Renou G; Ketari M; Toutée JP; Benzaken J
Rev Laryngol Otol Rhinol (Bord); 1989; 110(3):327-8. PubMed ID: 8638061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
